Skip to main content
SIGA
NASDAQ Life Sciences

Stockholders Approve 6.5 Million Share Increase for Incentive Plan

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$4.36
Mkt Cap
$312.717M
52W Low
$4.095
52W High
$9.62
52W Position info
6.5% above low
Off High info
55% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

SIGA is trading near its 52-week low of $4.095 (6.5% above the low).

Summary

SIGA Technologies' stockholders approved a 6.5 million share increase for its stock incentive plan, authorizing the potential issuance of shares that could dilute existing shareholders by over 10%.


Key Events · Corporate Governance and Compliance · SIGA

  • Stock Incentive Plan Expansion Approved

    Stockholders approved an amendment to the 2010 Stock Incentive Plan, increasing the aggregate number of shares authorized for issuance by 6,500,000 shares, from 8,500,000 to 15,000,000. This finalizes a proposal previously disclosed in proxy statements on April 28, 2026, and May 8, 2026.

  • Significant Potential Dilution

    If all 6.5 million newly authorized shares were issued under the plan, it would result in a potential dilution of approximately 10.4% for existing shareholders, based on the 62,436,105 shares outstanding as of the April 17, 2026, record date.

  • Routine Annual Meeting Approvals

    Stockholders also elected eight director nominees, ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor, and approved the non-binding advisory resolution on executive compensation.


Analysis · SIGA · Life Sciences

Stockholders of SIGA Technologies have approved an amendment to the 2010 Stock Incentive Plan, authorizing the company to issue an additional 6.5 million shares for equity compensation. This approval, which follows earlier proxy statements detailing the proposal, increases the total shares available under the plan to 15 million. If all these newly authorized shares were issued, it would result in a potential dilution of approximately 10.4% for existing shareholders, creating a significant overhang on the stock.

At the time of this filing, SIGA was trading at $4.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $312.7M. The 52-week trading range was $4.10 to $9.62. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SIGA - Latest Insights

SIGA
May 08, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.88
Real-time Price: $3.11 info
Change: -$1.77 (-36%) info
Market Cap: $223.062M info
SIGA
May 08, 2026, 4:01 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $4.80
Real-time Price: $3.11 info
Change: -$1.69 (-35%) info
Market Cap: $223.062M info
SIGA
May 07, 2026, 4:48 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.60
Real-time Price: $3.11 info
Change: -$1.49 (-32%) info
Market Cap: $223.062M info
SIGA
May 07, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.60
Real-time Price: $3.11 info
Change: -$1.49 (-32%) info
Market Cap: $223.062M info
SIGA
May 07, 2026, 4:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.72
Real-time Price: $3.11 info
Change: -$1.61 (-34%) info
Market Cap: $223.062M info